RT Journal
A1 Yu LX, Geba GP
T1 Generic pills from the patient perspective: Comment on “variations in pill appearance of antiepileptic drugs and the risk of nonadherence”
JF JAMA Internal Medicine
JO JAMA Internal Medicine
YR 2013
FD February 11
VO 173
IS 3
SP 208
OP 209
DO 10.1001/jamainternmed.2013.2283
UL http://dx.doi.org/10.1001/jamainternmed.2013.2283
AB 
Generic drug products are becoming increasingly important to health care. Nearly 80% of prescriptions filled in the United States are for generic drugs. At the US Food and Drug Administration (FDA), the Office of Generic Drugs (OGD) is responsible for the approval of generic drug products. The OGD assesses the safety, efficacy, and quality of generic drug products by making a finding of pharmaceutical equivalence and “bioequivalence.” A key principle is that generic drug products that reach health care providers and patients must be scientifically verified as appropriately substitutable for the brand-name products that are listed by the FDA as reference products.